Research Center for Emergency Medicine

Research Center for Emergency Medicine at @AarhusUni @AUHdk

[Stine Fjendbo Galili @StineFGalili]

Fluid administration in adult ED patients with sepsis. @MarieKJessen is shining climping the top of her Ph.D mountain @RECEM_CFA @AndersPerner

[AEM Journal @AcademicEmerMed]

The #refacedsepsis feasibility trial reduced fluids in ED #sepsis patients w/o shock randomized to restrictive fluid administration or standard care in 24h. Study from @MarieKJessen and @RECEM_CFA. Read @ https://t.co/KthMkkjyRI.
#AEM #EM @thenntgroup @SAEMonline @srrezaie

[Research Center for Emergency Medicine @RECEM_CFA]

Great work by @g_lauridsen and @Ilcor_org 👏

[Resuscitation @ResusJournal]

This @Ilcor_org systematic review identified very low certainty evidence for 13 different scores to predict outcomes.

None of these were able to reliably predict no chance of survival or favourable neurological outcome.

🔗 https://t.co/x5F8YRaFGm #ResusTwitter

[Research Center for Emergency Medicine @RECEM_CFA]

In this study of patients with in-hospital cardiac arrest, high assets💰 were associated with:
⬆️ higher survival
⏲️ longer duration of resuscitation among patients without return of spontaneous circulation

But the effect size may potentially be small

🔗https://t.co/qS8Gy3LK7I

[Research Center for Emergency Medicine @RECEM_CFA]

In this study by @Frederik_Trier et al, ten-year trends of trauma patients at a major trauma center showed:
⬆️median age
⬆️injury severity
⬆️number of fall injuries

👉 Adjusted 30-day mortality of trauma patients decreased slightly

🔗https://t.co/sRs9g4SiRW
#akutforskning

[Research Center for Emergency Medicine @RECEM_CFA]

In this systematic review, very low⬇️ certainty evidence was identified for 13 different pre-arrest prediction scores for outcome following in-hospital cardiac arrest.

❌No score was sufficiently reliable to support its use in clinical practice.

🔗https://t.co/pqhUl17VJV

[Stine Fjendbo Galili @StineFGalili]

20 patients included in the KeTMo study🔥.
Would patients with a daily use of opioids benefit from a low-dose of ketamine when presenting at the ED with acute pain? And would all the other patients with severe acute pain?
20/160
@RECEM_CFA
#EmergencyMedicine
#painmedicine

[Research Center for Emergency Medicine @RECEM_CFA]

First take your own pulse! Once again, our research team members joined the annual DHL 5k relay race.🏃‍♀️🏃💨 #akutforskning

[Research Center for Emergency Medicine @RECEM_CFA]

The results from the #refacedsepsis feasibility trial by @MarieKJessen et al. are out! 💧
⤵️

[Marie Jessen @MarieKJessen]

The results of the #refacedsepsis feasibility trial are now available.

24h crystalloid fluids were successfully reduced in sepsis patients without shock receiving restrictive fluids compared to standard care💦

🔗 https://t.co/PW9vmaqshH

@RECEM_CFA @AndersPerner @LarsWAndersen1

[Aarhus Universitet @AarhusUni]

Lars Wiuff Andersen, lektor på Institut for Klinisk Medicin på #aarhusuni, modtager Anders Jahre-prisen for yngre medicinske forskere som anerkendelse for forskningsresultater om behandling af hjertestop. Prisen uddeles af @UniOslo.

Læs: https://t.co/7PtLewTRoM

#dkforsk #dksund

[Research Center for Emergency Medicine @RECEM_CFA]

A huge congratulations to @LarsWAndersen1 for receiving the The Anders Jahre Award for young researchers! 👏👏

Read more:
🔗https://t.co/Tp0Pv7FXSC (in Danish)
🔗https://t.co/rvLZe8Jxxh (in English)

[Research Center for Emergency Medicine @RECEM_CFA]

.@LarsWAndersen1 presenting the results of the VAM-IHCA trial at #CCR22

[Research Center for Emergency Medicine @RECEM_CFA]

@Anders_Schmidt et al. ⤵️

[Salim R. Rezaie, MD @srrezaie]

The EPIC Trial: Electrode Positioning in Cardioverting Atrial Fibrillation via @MRamzyDO

Anterior-Lateral or Anterior-Posterior for cardioversion of #afib

https://t.co/YktYUVZ1wn

#FOAMed #FOAMcc #cardioversion #EPICtrial

[Research Center for Emergency Medicine @RECEM_CFA]

In this study, high socioeconomic status was associated with lower⬇️ odds of in-hospital cardiac arrest.

The findings were consistent across income💵, assets💰, and education📚 and persisted after adjustment for comorbidities.

🔗https://t.co/pVHuiyJMUv
@ResusJournal

[Asger Granfeldt @AsgerGranfeldt]

Excellent paper by Nikola Stankovic @nikostanko https://t.co/JgN1Bnkij7

[Morten Freil @MortenFreil]

Stort tillykke til Mia Blaabjerg, Center for Akutforskning på @AUHdk for prisen “Årets patientfokus”. Vigtigt fokus på at
inddrage de #pårørende til akut syge #kliniskeforsøg

[Research Center for Emergency Medicine @RECEM_CFA]

A huge congratulations to Mia Blaabjerg from @RECEM_CFA for winning the award for best clinical trial with a patient focus in Denmark 🏆🇩🇰.
Well deserved! 👏🎉

[Research Center for Emergency Medicine @RECEM_CFA]

ORGANIZATION AND MANAGEMENT DURING A #PANDEMIC 🦠

How do we prepare for a future pandemic or health crisis in #emergencymedicine? 🚨

What did we learn from the COVID-19 pandemic in #emergencymedicine?

Full report in collaboration with ICOA:
🔗https://t.co/YKJZ4RRUiK

[Stine Fjendbo Galili @StineFGalili]

First 2 patients included in the KeTMo study💥
Could patients with a daily use of opiods benefit from a low-dose of ketamine when presenting at the ED? And what about all the other patients with severe acute pain? 💥
2/160
@RECEM_CFA
#emergencymedicine #painmedicine

[Research Center for Emergency Medicine @RECEM_CFA]

2⃣ Mia Blaabjerg is nominated in the category of trials with a patient focus. 👥

She investigated the value of a nursing interventions targeting relatives in emergency medicine.

🔗 Meeting Relatives in Trauma Centers: https://t.co/MfmkRKqkCJ

[Research Center for Emergency Medicine @RECEM_CFA]

Two clinical trials from @RECEM_CFA are nominated for the best clinical trial in Denmark. 🏆

1⃣ @LarsWAndersen1 in the category: Investigator-initiated trials 🧑‍⚕️
2⃣ Mia Blaabjerg in the category: Patient focus 👥

Read more:
🔗https://t.co/I17f71b1Ho

🧵👇

[Research Center for Emergency Medicine @RECEM_CFA]

1⃣ @LarsWAndersen1 is nominated in the category of investigator-initiated trials. 🧑‍⚕️

He initiated two clinical trials (VAM-IHCA, COCA), both published in JAMA.

🔗VAM-IHCA: https://t.co/AbV7dCMASG
🔗COCA: https://t.co/eKhXXygAMr